Technologies

The guideline of the Joint National Committee (G-BA) requires laboratories to switch to a new test procedure for early detection of colon cancer. We have summarized what you need to consider in [...]

Now that summer is here, people are spending more and more time outside. Warm temperatures certainly make activities like swimming, hiking, jogging and picnicking more attractive. But forests and [...]

Darmstadt, Germany, June 27, 2018 – R-Biopharm Group announced today a collaborative agreement with Statens Serum Institute (SSI, Denmark), focusing on discovery and development of novel [...]

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.

The lab — a place for science and research where experiments and tests are on the daily agenda. Yet the world of the laboratory is changing. Digitalization and automation mark a new era. For [...]

Darmstadt, Germany and Puteaux, France, April 19, 2018 – R-Biopharm, a globally active life science company, and ELITechGroup, a leading company in sample-to-result molecular diagnostics, [...]

In Germany, more than 60,000 people contract colon cancer every year; over 25,000 die of the disease. Early detection could have prevented many such cases – yet in spite of that, only one in [...]

R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular [...]

As temperatures grow colder, the risk of catching the flu virus rises as well. This year, Australia is experiencing the worst flu epidemic in 15 years. Are Europe and North America also facing [...]